Erratum: A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity (Int J Mol Med (2014) 34: (725-732) DOI: 10.3892/ijmm.2014.1844);A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity

International Journal of Molecular Medicine

Volumn 34, Issue 3, 2014, Pages 725-732

  Liu, Wanjun ^a   Wang, Bei ^a   Ding, Hu ^a   Wang, Dao Wen ^a   Zeng, Hesong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Atherosclerosis; CYP2C8; Epoxyeicosatrienoic acids; Inflammation; Nuclear factor B; Reactive oxygen species

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; CYTOCHROME P450 2C8; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPOXYICOSATRIENOIC ACID; GLYCOPROTEIN GP 91; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 11,12-EPOXY-5,8,14-EICOSATRIENOIC ACID; CCL2 PROTEIN, HUMAN; DIHOMO GAMMA LINOLENIC ACID;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL MOTION; CYTOLOGY; DRUG EFFECTS; INTRACELLULAR SPACE; METABOLISM; PATHOLOGY; SMOOTH MUSCLE FIBER;

8,11,14-EICOSATRIENOIC ACID; CELL MOVEMENT; CHEMOKINE CCL2; CYTOCHROME P-450 CYP2C8; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTRACELLULAR SPACE; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE III; PPAR GAMMA; REACTIVE OXYGEN SPECIES; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84905031971     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2023.5280     Document Type: Erratum

References (41)

1. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126, 1999.
2. Guzik TJ, Korbut R and Adamek-Guzik T: Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54: 469-487, 2003. (Pubitemid 38029745)
3. Cai H: Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res 68: 26-36, 2005.
4. Madamanchi NR, Hakim ZS and Runge MS: Oxidative stress in atherogenesis and arterial thrombosisthe disconnect between cellular studies and clinical outcomes. J Thromb Haemost 3: 254-267, 2005. (Pubitemid 41623612)
5. Forstermann U: Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 5: 338-349, 2008.
6. Park JG and Oh GT: The role of peroxidases in the pathogenesis of atherosclerosis. BMB Rep 44: 497-505, 2011.
7. Cominacini L, Pasini AF, Garbin U, et al: Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-κB through an increased production of intracellular reactive oxygen species. J Biol Chem 275: 12633-12638, 2000. (Pubitemid 30241412)
8. Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN and Witztum JL: Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem 278: 1561-1568, 2003. (Pubitemid 36801384)
9. Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S and Witztum JL: Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 25: 1213-1219, 2005. (Pubitemid 40776611)
10. Bae YS, Lee JH, Choi SH, et al: Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res 104: 210-218, 2009.
11. Forman HJ and Torres M: Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 166: S4-S8, 2002. (Pubitemid 36015930)
12. Taniyama Y and Griendling KK: Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42: 1075-1081, 2003. (Pubitemid 37549058)
13. De Keulenaer GW, Ushio-Fukai M, Yin Q, et al: Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-α-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20: 385-391, 2000. (Pubitemid 30086094)
14. Hulsmans M and Holvoet P: The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med 14: 70-78, 2010.
15. Sury MD, Frese-Schaper M, Muhlemann MK, et al: Evidence that N-acetylcysteine inhibits TNF-α-induced cerebrovascular endothelin-1 upregulation via inhibition of mitogen- and stress-activated protein kinase. Free Radic Biol Med 41: 1372-1383, 2006. (Pubitemid 44466721)
16. Yang WS, Lee JM, Han NJ, Kim YJ, Chang JW and Park SK: Mycophenolic acid attenuates tumor necrosis factor-α-induced endothelin-1 production in human aortic endothelial cells. Atherosclerosis 211: 48-54, 2010.
17. Node K, Huo Y, Ruan X, et al: Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 1276-1279, 1999. (Pubitemid 29398616)
18. Fisslthaler B, Popp R, Kiss L, et al: Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-497, 1999. (Pubitemid 29470209)
19. Wu S, Chen W, Murphy E, et al: Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem 272: 12551-12559, 1997. (Pubitemid 27203348)
20. Zeldin DC, Foley J, Boyle JE, et al: Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas. Endocrinology 138: 1338-1346, 1997. (Pubitemid 27089795)
21. Michaelis UR, Fisslthaler B, Medhora M, Harder D, Fleming I and Busse R: Cytochrome P450 2C9-derived epoxyeicosa-trienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR). FASEB J 17: 770-772, 2003.
22. Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS and Liao JK: Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res 90: 1020-1027, 2002. (Pubitemid 34633869)
23. Liu L, Chen C, Gong W, et al: Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide. J Pharmacol Exp Ther 339: 451-463, 2011.
24. Wray J and Bishop-Bailey D: Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology. Exp Physiol 93: 148-154, 2008. (Pubitemid 350293969)
25. Wu J, Chen C, Zeng HS and Wang DW: The protective effects of cytochrome P450 gene on atherosclerosis induced by high fat diet in different week old mice. Mol Cardiol Chin 11: 37-41, 2011.
26. Sun J, Huang SH, Zhu YC, et al: Anti-oxidative stress effects of Herba leonuri on ischemic rat hearts. Life Sci 76: 3043-3056, 2005. (Pubitemid 40585706)
27. Simoncini T, Maffei S, Basta G, et al: Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res 87: 19-25, 2000. (Pubitemid 30456930)
28. Liu X, Pan L, Gong Q and Zhu Y: Leonurine (SCM-198) improves cardiac recovery in rat during chronic infarction. Eur J Pharmacol 649: 236-241, 2010.
29. Wilson SH, Best PJ, Edwards WD, et al: Nuclear factor-κB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis 160: 147-153, 2002. (Pubitemid 34082720)
30. Collins T and Cybulsky MI: NF-κB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107: 255-264, 2001. (Pubitemid 32157955)
31. Brasier AR: The nuclear factor-κB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86: 211-218, 2010.
32. Marx N, Duez H, Fruchart JC and Staels B: Peroxisome proliferator- activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res 94: 1168-1178, 2004. (Pubitemid 38656403)
33. Ricote M, Li AC, Willson TM, Kelly CJ and Glass CK: The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391: 79-82, 1998. (Pubitemid 28079218)
34. Cipollone F, Fazia M, Iezzi A, et al: Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol 24: 1259-1265, 2004. (Pubitemid 38880018)
35. Dehmer T, Heneka MT, Sastre M, Dichgans J and Schulz JB: Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NF κB and iNOS activation. J Neurochem 88: 494-501, 2004. (Pubitemid 38084565)
36. Castrillo A and Tontonoz P: PPARs in atherosclerosis: the clot thickens. J Clin Invest 114: 1538-1540, 2004. (Pubitemid 40385542)
37. Wang H, Lin L, Jiang J, et al: Up-regulation of endothelial nitricoxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways. J Pharmacol Exp Ther 307: 753-764, 2003. (Pubitemid 37310693)
38. Lee PC, Ho IC and Lee TC: Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. Toxicol Sci 85: 541-550, 2005.
39. Zhang T, Zhang X, Yu W, et al: Effects of chemokine-like factor 1 on vascular smooth muscle cell migration and proliferation in vascular inflammation. Atherosclerosis 226: 49-57, 2013.
40. Caglayan E, Romeo GR, Kappert K, et al: Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells. PLoS One 5: e13608, 2010.
41. Nakagawa M, Ohno T, Maruyama R, et al: Sesquiterpene lactone suppresses vascular smooth muscle cell proliferation and migration via inhibition of cell cycle progression. Biol Pharm Bull 30: 1754-1757, 2007. (Pubitemid 47407693)